InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.00%
)
US TECH 100
18,926.00
(
-0.46%
)
Dow Jones
41,393.78
(
0.00%
)
Brent Oil
71.83
(
0.62%
)
Bitcoin
58,541.53
(
-1.07%
)
Post# of 253125
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

investorgold2002

Send PM Follow Ignore
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

investorgold2002

Re: DewDiligence post# 121505

Sunday, 06/12/2011 5:24:00 PM

Sunday, June 12, 2011 5:24:00 PM

Post# of 253125
thanks dew informative post..
I am not sure I agree with your characterization of "legacy business" that wheeler was talking about.

you said the below.

"but rather their branded biologics approved via the ordinary BLA pathway. For obvious reasons, companies that have large sales from branded biologics do not want MNTA’s biogenerics to succeed. "
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up